Search
for
Sort by
Research 121–150 of 151
- The association of medications and supplements with human male reproductive health: a systematic review
- Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem)
- Empirical evidence of observer bias in randomized clinical trials: updated and expanded analysis of trials with both blinded and non-blinded outcome assessors
- The Men’s Training Cup Keep Training: a masturbation aid improves intravaginal ejaculatory latency time and Erection Hardness Score in patients who are unable to delay ejaculation
- Zolpidem-Associated Dermatitis Artefacta—An Unusual Cause of Cicatricial Alopecia
- Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy
- Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland
- Sodium Valproate Induced Alopecia: A Case Series
- Hair Loss Associated with Sertraline: Two Case Reports and Review
- Medical Therapy for Female Pattern Hair Loss (FPHL)
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Repurposing Finasteride and Serotonin Reuptake Inhibitors as Novel Antimicrobials: A Dual-Action Approach to Target Bacterial and Fungal Pathogens
- Understanding the Secular Decline in Testosterone: Mechanisms, Consequences, and Clinical Perspectives
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Mirtazapine-induced Gynecomastia: An Unknown Side Effect?
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Assessing Causality Between Androgenetic Alopecia with Depression: A Bidirectional Mendelian Randomization Study
- Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE
- Transcranial focused ultrasound-mediated unbinding of phenytoin from plasma proteins for suppression of chronic temporal lobe epilepsy in a rodent model
- Psychological Aspect of Alopecia
- Selection of Anti-Depressants in Geriatric Dermatoses- A Questionnaire Study of Dermatologists in Western Rajasthan, India
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- The First Visit: Consult and Workup Before Sperm Banking
- Hair Loss Associated with Sertraline: Two Case Reports and Review
- ZALCITABINE
- SARGRAMOSTIN
- Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of Allopregnanolone in Adult Male Rats
- Research on Mental Stress Recognition of Depressive Disorders in Patients With Androgenic Alopecia Based on Machine Learning and Fuzzy K-Means Clustering